1. Home
  2. VYNE vs SPPL Comparison

VYNE vs SPPL Comparison

Compare VYNE & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VYNE Therapeutics Inc.

VYNE

VYNE Therapeutics Inc.

HOLD

Current Price

$0.59

Market Cap

19.0M

Sector

Health Care

ML Signal

HOLD

SPPL

SIMPPLE LTD.

N/A

Current Price

$2.89

Market Cap

17.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VYNE
SPPL
Founded
2003
2016
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.0M
17.4M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
VYNE
SPPL
Price
$0.59
$2.89
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
418.2K
4.0K
Earning Date
03-05-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$524,000.00
$4,591,508.00
Revenue This Year
N/A
N/A
Revenue Next Year
$16.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.29
24.27
52 Week Low
$0.28
$2.18
52 Week High
$2.94
$7.00

Technical Indicators

Market Signals
Indicator
VYNE
SPPL
Relative Strength Index (RSI) 68.94 34.59
Support Level $0.55 $2.97
Resistance Level $0.57 $3.25
Average True Range (ATR) 0.02 0.27
MACD -0.00 0.02
Stochastic Oscillator 91.01 34.95

Price Performance

Historical Comparison
VYNE
SPPL

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

Share on Social Networks: